A significant peptide update in 2026 has set in motion a significant regulatory shift for some of the most widely researched compounds in the peptide space. Following an announcement by Robert F. Kennedy Jr., United States Secretary of Health and Human Services, 12 peptides previously classified under FDA Category 2 will be removed from that
There is no shortage of information about starting a peptide cycle. Protocols, dosing schedules, and expected benefits are well documented. What receives far less attention is the other end of the process. Stopping Peptide Therapy is a biological event in its own right, and for a meaningful proportion of people, the transition off a cycle
Among the compounds generating serious interest in longevity science, Epitalon stands out for its depth of research and the specificity of its mechanism. This synthetic tetrapeptide, composed of the amino acid sequence Alanine, Glutamic acid, Aspartic acid, and Glycine, was developed as a structural analogue of a peptide naturally produced by the pineal gland. Decades
